StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Oxprenolol

HCID 4631
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
6452-71-7
Standard-SMILES
C=CCOc1ccccc1OCC(O)CNC(C)C
InChIKey
CEMAWMOMDPGJMB-UHFFFAOYSA-N
Summenformel
C15H23NO3
Durchschnittliche Molmasse
265,35 g/mol
Monoisotopische Masse
265,1677936

Überblick

1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)-2-propanol is an aromatic ether.

Namen und Bezeichner

Bevorzugter Name
Oxprenolol
IUPAC
1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol
Lokaler Name
Oxprenolol
Englischer Name
oxprenolol
Summenformel
C15H23NO3
Molmasse
265.35

Namen und Synonyme

oxprenolol6452-71-7CoretalOxprenololum519MXN9YZRDTXSID10438352-Propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyloxy)phenoxy)-2-Propanol, 1-[(1-methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-{2-hydroxy-3-[2-(prop-2-en-1-yloxy)phenoxy]propyl}(propan-2-yl)amineoxprenololo(2-hydroxy-3-(2-(prop-2-en-1-yloxy)phenoxy)propyl)(propan-2-yl)amineTrasicor, Slow
Weitere Namen anzeigen
TevacorOxenalolAids001596Aids-001596Oxprenolol-d7oxprenolol USP/EP/BPCoretal (hydrochloride)1-(2-allyloxyphenoxy)-3-isopropylaminopropan-2-ol
RefChem:857811DTXCID9023835C07AA02229-257-9245-359-6dl-Oxprenolol(+-)-OxprenololOsprenololo [DCIT]

Datenbank-Bezeichner

CAS
6452-71-7
PubChem CID
4631

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
2,1
Polarare Oberfläche (TPSA)
50,7 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
9
Schwere Atome
19
Formalladung
0
Komplexität
246

Experimentelle und physikochemische Eigenschaften

Chemical ClassesOther Uses -> Pharmaceuticals
Drugs · 2 Einträge

Pharmaceuticals

Pharmaceuticals -> Antihypertensives

LogP · 2 Einträge

2.10

2.25

Solubility6.80e-01 g/L
Human DrugsPharmaceuticals
Physical DescriptionSolid
Dissociation Constants9.57
Collision Cross Section161.7 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

Physikochemische Eigenschaften

Schmelzpunkt

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P262, P264, P270, P271, P280, P301+P316, P302+P352, P304+P340, P316, P321, P330, P361+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Gefahrenhinweise

Regulatory Information2-Propanol, 1-(1-methylethyl)amino-3-2-(2-propenyloxy)phenoxy-: Does not have an individual approval but may be used under an appropriate group standard
Hazards SummaryAllergic contact dermatitis reported in a pharmaceutical worker; [Kanerva, p. 1822] See Propranolol.
Hazard Classes and CategoriesAcute Tox. 3 (100%)

Toxikologische Informationen

Adverse EffectsSkin Sensitizer - An agent that can induce an allergic reaction in the skin.

Sicherheitsdaten

Alarmwort
Achtung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H301

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

C - Cardiovascular system

QC - Cardiovascular system

Pharmacodynamics · 1 Eintrag

Oxprenolol is a non-selective beta blocker with some intrinsic sympathomimetic activity. Oxprenolol is a lipophilic molecule and hence, it is able to cross the blood-brain barrier. As such, it is associated with a higher incidence of CNS-related side effects than hydrophilic ligands such as atenolol, sotalol and nadolol. Oxprenolol is an potent beta-blocker and should not be administered to asthmatics because it can cause irreversible airway failure and inflammation.

Mechanism of Action · 1 Eintrag

Like other beta-adrenergic antagonists, oxprenolol competes with adrenergic neurotransmitters such as catecholamines for binding at sympathetic receptor sites. Like propranolol and timolol, oxprenolol binds at beta(1)-adrenergic receptors in the heart and vascular smooth muscle, inhibiting the effects of the catecholamines epinephrine and norepinephrine and decreasing heart rate, cardiac output, and systolic and diastolic blood pressure. It also blocks beta-2 adrenergic receptors located in bronchiole smooth muscle, causing vasoconstriction. By binding beta-2 receptors in the juxtaglomerular apparatus, oxprenolol inhibits the production of renin, thereby inhibiting angiotensin II and aldosterone production. Oxprenolol therefore inhibits the vasoconstriction and water retention due to angiotensin II and aldosterone, respectively.

Biological Half-Life1-2 hours
Metabolism/Metabolites · 2 Einträge

Hepatic.

Oxoprenolol has known human metabolites that include Oxprenolol glucuronide.

MeSH Pharmacological Classification · 6 Einträge

Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.

Zugehörige Reaktionen

1
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 328893
HRID 328893als Produkt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
DTXSID
DTXSID1043835
ChEMBL
CHEMBL546
ChEBI
CHEBI:91704
UNII
519MXN9YZR
EC Number
229-257-9
Nikkaji
J318.375K、J8.410G
78 · 78-80°
Siedepunkt
408.57 °C · 408.57°C (rough estimate)
Dichte
1.0479 · 1.0479 (rough estimate)
Brechungsindex
1.5 · 1.5000 (estimate)
Löslichkeit
Dichloromethane (Slightly), Methanol (Slightly)
Aggregatzustand
Solid
pka
13.89 · 13.89±0.20(Predicted)
Farbe
White to Off-White
Stabilität
Stable under recommended storage conditions., Stable Under Recommended Storage C

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.

Drugs used to cause dilation of the blood vessels.

Absorption, Distribution and ExcretionOral bioavailability is 20-70%.
Cellular LocationsMembrane
Metabolite PathwaysOxprenolol Action Pathway

Verwendung und Herstellung

Uses · 2 Einträge

Used as a beta-blocking agent; [Kanerva, p. 1822]

Use (kg; approx.) in Germany (2009): >50

Use ClassificationPharmaceuticals

Anwendungen

BeschreibungOxprenolol induced contact dermatitis in a worker at a pharmaceutical plant, in the division for drug synthesis. Epichlorhydrin was also used for the production of both propranolol and oxprenolol.

VerwendenOxprenolol is a free base of Oxprenolol Hydrochloride(O870500) which is a β-Adrenergic blocker. Antihypertensive, antianginal, antiarrhythmic.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Isopropylamin1-Chlor-2,3-epoxypropan